Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 19.

Eloranta, J J; Stieger, B; Kullak-Ublick, G A (2014). Bile salt transporters. In: You, G; Morris, M E. Drug Transporters: Molecular Characterization and Role in Drug Disposition. Hoboken, New Jersey: Wiley Series in Drug Discovery and Development, John Wiley & Sons Inc.., 127-139.

Baur, K; Mertens, J C; Schmitt, J; Iwata, R; Stieger, B; Eloranta, J J; Frei, P; Stickel, F; Dill, M T; Seifert, Burkhardt; Bischoff Ferrari, H A; von Eckardstein, A; Bochud, P Y; Müllhaupt, B; Geier, A (2012). Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin D Receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver International, 32(4):635-643.

Scharl, M; Mwinyi, J; Fischbeck, A; Leucht, K; Eloranta, J J; Arikkat, J; Pesch, T; Kellermeier, S; Mair, A; Kullak-Ublick, G A; Truninger, K; Noreen, F; Regula, J; Gaj, P; Pittet, V; Mueller, C; Hofmann, C; Fried, M; McCole, D F; Rogler, G (2012). Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. Inflammatory Bowel Diseases, 18(5):900-912.

Ma, L; Jüttner, M; Kullak-Ublick, G A; Eloranta, J J (2012). Regulation of the gene encoding the intestinal bile acid transporter ASBT by the caudal-type homeobox proteins CDX1 and CDX2. American Journal of Physiology. Gastrointestinal and Liver Physiology, 302(1):G123-33.

Eloranta, J J; Wenger, C; Mwinyi, J; Hiller, C; Gubler, C; Vavricka, S R; Fried, M; Kullak-Ublick, G A (2011). Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenetics and Genomics, 21(9):559-564.

Mwinyi, J; Wenger, C; Eloranta, J J; Kullak-Ublick, G A (2010). Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients. World Journal of Gastroenterology, 16(31):3888-3896.

Dziunycz, P; Iotzova-Weiss, G; Eloranta, J J; Läuchli, S; Hafner, J; French, L E; Hofbauer, G F L (2010). Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation. Journal of Investigative Dermatology, 130(11):2686-2689.

Klein, K; Jungst, C; Mwinyi, J; Stieger, B; Krempler, F; Patsch, W; Eloranta, J J; Kullak-Ublick, G A (2010). The Human Organic Anion Transporter Genes OAT5 and OAT7 Are Transactivated by Hepatocyte Nuclear Factor-1{alpha} (HNF-1{alpha}). Molecular Pharmacology, 78(6):1079-1087.

Wojtal, K A; Eloranta, J J; Hruz, P; Gutmann, H; Drewe, J; Beglinger, C; Fried, M; Kullak-Ublick, G A; Vavricka, S R (2009). Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metabolism and Disposition, 37(9):1871-1877.

Eloranta, J J; Hiller, C; Hausler, S; Stieger, B; Kullak-Ublick, G A (2009). Vitamin D3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter. Molecular Pharmacology, 76(5):1062-1071.

Kullak-Ublick, G A; Eloranta, J J (2009). Nuclear receptor regulation of bile acid transporters. In: Keppler, D; Beuers, U; Steihl, A; Trauner, M. Bile Acid Biology and Therapeutic Actions. Berlin: Springer, 111-114.

Klein, K; Kullak-Ublick, G A; Wagner, M; Trauner, M; Eloranta, J J (2009). Hepatocyte nuclear factor-4{alpha} and bile acids regulate human concentrative nucleoside transporter-1 gene expression. American Journal of Physiology. Gastrointestinal and Liver Physiology, 296(4):G936-G947.

Gee, J M W; Eloranta, J J; Ibbitt, J C; Robertson, J F R; Ellis, I O; Williams, T; Nicholson, R I; Hurst, H C (2009). Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival. Journal of Pathology, 217(1):32-41.

Eloranta, J J. Transcriptional regulation of genes encoding drug and bile acid transporters: implications for liver and intestinal diseases. 2009, University of Zurich, Faculty of Medicine.

Zaïr, Z M; Eloranta, J J; Stieger, B; Kullak-Ublick, G A (2008). Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney. Pharmacogenomics, 9(5):597-624.

Eloranta, J J; Kullak-Ublick, G A (2008). The role of FXR in disorders of bile acid homeostasis. Physiology, 23:286-295.

Georgiev, P; Navarini, A A; Eloranta, J J; Lang, K S; Kullak-Ublick, G A; Nocito, A; Dahm, F; Jochum, W; Graf, R; Clavien, P-A (2007). Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse. Gut, 56(1):121-128.

Eloranta, J J; Kullak-Ublick, G A (2007). Enterohepatic bile acid transporters and transcriptional control of their expression. In: Young, G; Morris, M E. Drug Transporters: Molecular characterization and role in drug disposition. Hoboken: Wiley and Sons, 201-221.

Eloranta, J J; Kullak-Ublick, G A (2007). Regulation of hepatic and intestinal bile acid transport by FXR-controlled pathways. In: Keppler, D; Beuers, U; Leuschner, U; Stiehl, A; Trauner, M; Paumgartner, G. Bile Acids: Biological Actions and Clinical Relevance. Dordrecht (NL): Springer, 115-120.

This list was generated on Thu Sep 19 08:53:03 2019 CEST.